Platinum Industries Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue rose 23.3% to ₹121.3 Cr, but EBITDA margin fell to 8.9% (from 13.8%) and PAT dropped to ₹7.6 Cr (from ₹11 Cr) on freight and Palghar ramp-up costs.
- Call
- Guides 35% growth
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Q2 FY27 revenue rose 23.3% to ₹121.3 Cr, but EBITDA margin fell to 8.9% (from 13.8%) and PAT dropped to ₹7.6 Cr (from ₹11 Cr) on freight and Palghar ramp-up costs.
Platinum Industries filed a Crisil monitoring agency report on IPO proceeds for the quarter ended 30 September 2026. The report states no deviation from offer objects.
Platinum Industries Ltd reported revenue from operations of ₹121.3 Cr (+23.3% YoY) and net profit of ₹7.6 Cr (-30.9% YoY) for Q2 FY27.
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.
Platinum Industries Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Platinum Industries' subsidiary, Rivadu Lifesciences, entered an exclusive sale/purchase agreement with Korea-based CAREGEN Co., Ltd. The partnership targets the Indian market for Caregen's functional food products.
Platinum Industries Limited held its 6th Annual General Meeting on September 24, 2026. The meeting covered financial statement adoption, director re-appointment, and related party transactions.